Jean George
CIK 1291804 · last filed 2024-02-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALXO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PORTOLA VALLEY, CA 94028
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. (CYT) Delisted | Director | 2,458,415 | $3.02 | $7.42M | $0 | 4 | 2024-02-16 |
| Calithera Biosciences, Inc. (CALA) Delisted | Director | 90,504 | $0.00 | $27 | $3.00M | 8 | 2021-06-14 |
| ALXO | 10%+ Owner | 309,222 | $1.13 | $349.4K | $68.40M | 1 | 2020-07-22 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 5,127 | $178.75 | $916.5K | -$57.46M | 15 | 2020-01-24 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | 15,127 | $8.54 | $129.2K | $3.11M | 4 | 2018-06-07 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 5,786 | — | — | -$51.43M | 9 | 2015-07-23 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 27,939 | — | — | $0 | 1 | 2013-05-30 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Director | — | $1.95 | — | $0 | 1 | 2007-05-03 |
Recent Filings · Page 4 of 5
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-09 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-10 | ACCELERON PHARMA INC (XLRN) Delisted | Sell (S) | −97,407 | -$4.37M | EDGAR |
| 2014-11-04 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Mixed | — | -$335.9K | EDGAR |
| 2014-10-09 | Calithera Biosciences, Inc. (CALA) Delisted | Mixed | +2,110,082 | $3.00M | EDGAR |
| 2014-07-31 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Sell (S) | −29,157 | -$585.8K | EDGAR |
| 2014-01-22 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Mixed | −2,000,000 | -$702.9K | EDGAR |
| 2013-12-09 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-11-18 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Sell (S) | −4,025,000 | -$49.19M | EDGAR |
| 2013-09-26 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | +2,504,051 | $0 | EDGAR |
| 2013-06-20 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.